Dr Adela Valdez joins Ethics Talk to discuss her article, coauthored with Lala Forrest, Alessandra Jimenez, and Dr Kim-Thu Pham: “How Should Medical Schools Foster Equity and Inclusion in Admissions?”
Dr Tonya Fancher joins Ethics Talk to discuss her article, coauthored with Dr Marjorie Westervelt, Dr Darius Billingsley, and Maya London: “Three Things Schools Should Do to Make Advancement Assessment Just”
Dr Barbara Barzansky joins Ethics Talk to discuss her article, coauthored with Drs Robert B. Hash, Veronica Catanese, and Donna Waechter: “What Is the Role of Accreditation in Achieving Medical School Diversity?”
Carly P. Smith, PhD and Daniel R. George, PhD, MSc
Invisibility of racial inequity and gender inclusion in clinical research means key features of disease etiology and symptom presentation are unaccounted for.
AMA J Ethics. 2021;23(7):E563-568. doi:
10.1001/amajethics.2021.563.
Eleftherios Mylonakis, MD and Panayiotis D. Ziakas, MD, MSc, PhD
Allocating resources for interventions requires consensus among stakeholders with a plurality of perspectives about how to weigh antimicrobial stewardship interventions’ risks and benefits.
AMA J Ethics. 2021;23(8):E631-638. doi:
10.1001/amajethics.2021.631.
A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021;23(9):E712-720. doi:
10.1001/amajethics.2021.712.